117 related articles for article (PubMed ID: 37468096)
1. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
Brustia R; Bouattour M; Allaire M; Lequoy M; Hollande C; Regnault H; Blaise L; Ganne-Carrié N; Vilgrain V; Larrey E; Lim C; Scatton O; Mouhadi SE; Ozenne V; Paye F; Balladur P; Dohan A; Massault PP; Pol S; Dioguardi Burgio M; Sepulveda A; Cauchy F; Luciani A; Sommacale D; Leroy V; Calderaro J; Roudot-Thoraval F; Nault JC; Amaddeo G;
Ann Hepatol; 2023; 28(6):101141. PubMed ID: 37468096
[TBL] [Abstract][Full Text] [Related]
2. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area.
Amaddeo G; Brustia R; Allaire M; Lequoy M; Hollande C; Regnault H; Blaise L; Ganne-Carrié N; Séror O; Larrey E; Lim C; Scatton O; El Mouhadi S; Ozenne V; Paye F; Balladur P; Dohan A; Massault PP; Pol S; Dioguardi Burgio M; Vilgrain V; Sepulveda A; Cauchy F; Luciani A; Sommacale D; Leroy V; Roudot-Thoraval F; Bouattour M; Nault JC;
JHEP Rep; 2021 Feb; 3(1):100199. PubMed ID: 33163949
[TBL] [Abstract][Full Text] [Related]
3. Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis.
Piñero F; Marciano S; Fernández N; Silva J; Anders M; Zerega A; Ridruejo E; Romero G; Ameigeiras B; D'Amico C; Gaite L; Bermúdez C; Reggiardo V; Colombato L; Gadano A; Silva M
World J Gastroenterol; 2019 Jul; 25(27):3607-3618. PubMed ID: 31367160
[TBL] [Abstract][Full Text] [Related]
4. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
[TBL] [Abstract][Full Text] [Related]
5. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
[TBL] [Abstract][Full Text] [Related]
6. Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma.
Cabibbo G; Petta S; Barbara M; Attardo S; Bucci L; Farinati F; Giannini EG; Negrini G; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Virdone R; Marra F; Mega A; Morisco F; Benvegnù L; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Olivani A; Masotto A; Nardone G; Colecchia A; Persico M; Craxì A; Trevisani F; Cammà C;
J Hepatol; 2017 Jul; 67(1):65-71. PubMed ID: 28192185
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and surgical outcomes for spontaneous rupture of BCLC stages A and B hepatocellular carcinoma: a case-control study.
Li J; Huang L; Liu CF; Cao J; Yan JJ; Xu F; Wu MC; Yan YQ
World J Gastroenterol; 2014 Jul; 20(27):9121-7. PubMed ID: 25083085
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital.
Pomej K; Scheiner B; Hartl L; Balcar L; Meischl T; Mandorfer M; Reiberger T; Müller C; Trauner M; Pinter M
PLoS One; 2021; 16(8):e0256544. PubMed ID: 34437610
[TBL] [Abstract][Full Text] [Related]
9. Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.
Huang Y; Chen B; Liu N; Li N; Dao H; Chen W; Yang J
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):498-508. PubMed ID: 28157070
[TBL] [Abstract][Full Text] [Related]
10. Effective therapeutic options for elderly patients with hepatocellular carcinoma: A nationwide cohort study.
Shin J; Yu JH; Jin YJ; Suh YJ; Kim DH; Byun S; Lee JW
Medicine (Baltimore); 2019 Jul; 98(30):e16150. PubMed ID: 31348228
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hepatocellular carcinoma in a tertiary Romanian center. Deviations from BCLC recommendations and influence on survival rate.
Radu P; Groza I; Iancu C; Al Hajjar N; Andreica V; Sparchez Z
J Gastrointestin Liver Dis; 2013 Sep; 22(3):291-7. PubMed ID: 24078986
[TBL] [Abstract][Full Text] [Related]
12. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
[TBL] [Abstract][Full Text] [Related]
13. Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study.
Muñoz-Martínez S; Sapena V; Forner A; Bruix J; Sanduzzi-Zamparelli M; Ríos J; Bouattour M; El-Kassas M; Leal CRG; Mocan T; Nault JC; Alves RCP; Reeves HL; da Fonseca L; García-Juárez I; Pinato DJ; Varela M; Alqahtani SA; Alvares-da-Silva MR; Bandi JC; Rimassa L; Lozano M; González Santiago JM; Tacke F; Sala M; Anders M; Lachenmayer A; Piñero F; França A; Guarino M; Elvevi A; Cabibbo G; Peck-Radosavljevic M; Rojas Á; Vergara M; Braconi C; Pascual S; Perelló C; Mello V; Rodríguez-Lope C; Acevedo J; Villani R; Hollande C; Vilgrain V; Tawheed A; Ferguson Theodoro C; Sparchez Z; Blaise L; Viera-Alves DE; Watson R; Carrilho FJ; Moctezuma-Velázquez C; D'Alessio A; Iavarone M; Reig M
Liver Int; 2022 Aug; 42(8):1891-1901. PubMed ID: 35608939
[TBL] [Abstract][Full Text] [Related]
14. Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
Qi X; Wang D; Su C; Li H; Guo X
Oncotarget; 2015 Jul; 6(21):18715-33. PubMed ID: 26243835
[TBL] [Abstract][Full Text] [Related]
15. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study.
Vitale A; Morales RR; Zanus G; Farinati F; Burra P; Angeli P; Frigo AC; Del Poggio P; Rapaccini G; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Giannini EG; Caturelli E; Chiaramonte M; Trevisani F; Cillo U;
Lancet Oncol; 2011 Jul; 12(7):654-62. PubMed ID: 21684210
[TBL] [Abstract][Full Text] [Related]
16. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of untreated hepatocellular carcinoma.
Giannini EG; Farinati F; Ciccarese F; Pecorelli A; Rapaccini GL; Di Marco M; Benvegnù L; Caturelli E; Zoli M; Borzio F; Chiaramonte M; Trevisani F;
Hepatology; 2015 Jan; 61(1):184-90. PubMed ID: 25234419
[TBL] [Abstract][Full Text] [Related]
18. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group.
Torzilli G; Belghiti J; Kokudo N; Takayama T; Capussotti L; Nuzzo G; Vauthey JN; Choti MA; De Santibanes E; Donadon M; Morenghi E; Makuuchi M
Ann Surg; 2013 May; 257(5):929-37. PubMed ID: 23426336
[TBL] [Abstract][Full Text] [Related]
19. Association of Hepatitis B Virus DNA Level and Follow-up Interval With Hepatocellular Carcinoma Recurrence.
Wang W; Tian SL; Wang H; Shao CC; Wang YZ; Li YL
JAMA Netw Open; 2020 Apr; 3(4):e203707. PubMed ID: 32338753
[TBL] [Abstract][Full Text] [Related]
20. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH
Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]